Invention Grant
- Patent Title: Drug combinations for reducing cell viability and/or cell proliferation
-
Application No.: US16300313Application Date: 2017-05-09
-
Publication No.: US11357769B2Publication Date: 2022-06-14
- Inventor: Anand Selvaraj , Peter Smith
- Applicant: Eisai R&D Management Co., Ltd.
- Applicant Address: JP Tokyo
- Assignee: Eisai R&D Management Co., Ltd.
- Current Assignee: Eisai R&D Management Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Buchanan Ingersoll & Rooney PC
- International Application: PCT/US2017/031771 WO 20170509
- International Announcement: WO2017/196854 WO 20171116
- Main IPC: A61K31/497
- IPC: A61K31/497 ; A61K31/535 ; A61K31/4706 ; A61K31/506 ; A61K31/517 ; A61P35/00 ; A61K39/395
Abstract:
Provided herein is a combination of agents for reducing cell viability and/or cell proliferation. The combination comprises an FGFR4 inhibitor and an EGFR inhibitor.
Public/Granted literature
- US20190117640A1 DRUG COMBINATIONS FOR REDUCING CELL VIABILITY AND/OR CELL PROLIFERATION Public/Granted day:2019-04-25
Information query
IPC分类:
